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Novel aspects in regulated expression of the renal type IIa
Na/Pi-cotransporter. Proximal tubular phosphate (Pi) reab-
sorption is a key element in overall phosphate homeostasis;
physiologic/pathophysiologic alterations are related to the con-
trol of brush border membrane expression (regulated endocy-
tosis) of the type IIa sodium (Na)/phosphate(Pi)-cotransporter
(NaPi-IIa). The carboxy terminus of NaPi-IIa contains se-
quences important for its apical delivery/expression; the last
three amino acids are involved in PSD95/DglA/ZO-1 (PDZ) in-
teractions involving NaPi-IIa, Na/H exchanger-regulatory fac-
tor 1 (NHERF1/2), and PDZK1/2 (apical scaffold). Regulated
endocytosis of NaPi-IIa [e.g., parathyroid hormone (PTH)-
induced] is reduced in megalin-deficient mice; internalization
occurs via clathrin-coated structures, early endosomes, and fi-
nally leads to lysosomal degradation. NaPi-IIa contains, in the
third intracellular loop, a sequence motif required for internal-
ization. Different hormonal [e.g., PTH, atrial natriuretic pep-
tide (ANP), also nitric oxide (NO)] and nonhormonal factors
activate a variety of intracellular signaling cascades [protein
kinase A (PK-A), protein kinase C (PK-C), protein kinase G
(PK-G), extracellular receptor kinase (ERK)-1/2] leading (by
unknown mechanisms) to NaPi-IIa internalization. Different
phosphatonins [e.g., fibroblast growth factor (FGF)-23, frizzled
related protein (FRP)-4, matrix extracellularphosphoglycopro-
tein (MEPE)], associated with different pathophysiologic states
of renal Pi–handling, seem also to control apical expression of
NaPi-IIa. Internalization of NaPi-IIa first requires its removal
from the apical scaffold. This scaffold can also be considered
as a regulatory scaffold containing also protein kinase A (PK-
A)–anchoring proteins (AKAPs, ezrin) and the apical PTH re-
ceptor. The role of the different components of the regulatory
scaffold in regulated endocytosis of NaPi-IIa is at present un-
known.
Renal proximal tubular phosphate (Pi) reabsorption
is a key element in overall Pi homeostasis. It is sec-
ondary active and involves apical Na/Pi-cotransport sys-
tems (NaPi-IIa and NaPi-IIc); gene deletion experiments
suggest that NaPi-IIa accounts roughly for 70% to 80%
of brush border membrane Na/Pi-cotransport activity
(reviewed in [1–3]). A significant part of the remaining
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Na/Pi-cotransport activity might be related to NaPi-IIc
[4, 5], an isoform that appears to play an important role
in weaning animals [5]. In this review we only discuss phe-
nomena related to NaPi-IIa, although similar regulatory
properties and mechanisms may also apply to NaPi-IIc
([4], and unpublished observations).
Consistent with the dominant role in proximal tubular
Na-dependent Pi-reabsorption [6], NaPi-IIa is the target
of many physiologic/pathophysiologic processes leading
to altered renal Pi-reabsorption (reviewed in [1, 2, 3, 7,
8]). Interestingly, regulated renal Pi-reabsorption is asso-
ciated with altered brush border membrane NaPi-IIa ex-
pression (reviewed in [1–3]). Thereby, the brush border
membrane content of type NaPi-IIa protein is codeter-
mined by apical delivery/insertion, apical retention (scaf-
folding), and apical retrieval/endocytosis. It is at present
not known whether direct control of the activity of indi-
vidual NaPi-IIa molecules also contributes to altered Na-
dependent Pi-reabsorption; such activity changes could
be related to, for example, post-translational modifica-
tions (e.g., phosphorylation; similar to NHE3 [9]). In
addition, sequence mutations in NaPi-IIa have been
suggested to contribute to genetically determined renal Pi
wasting [10]. However, we have not been able to support
these interpretations in oocyte and OK cell expression
studies using NaPi-IIa and corresponding site directed
mutagenesis [11].
In this review, we discuss recent observations related
to mechanisms determining apical delivery/positioning
of NaPi-IIa, describe novel experiments related to the
retrieval/intracellular traffic of the transporter, and sum-
marize intracellular signaling mechanisms contributing
to the regulated expression of NaPi-IIa in response to
different systemic factors involved in Pi homeostasis.
APICAL DELIVERY/POSITIONING (APICAL
SCAFFOLD)
Experiments to identify molecular signals involved
in the apical expression of NaPi-IIa were conducted in
opossum kidney (OK) cells, based on the observation
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Fig. 1. Requirements for apical expression
(delivery/positioning) of NaPi-Iia. (A) Opos-
sum kidney (OK) cells were transfected with
wild type NaPi-IIa (WT-NaPi-IIa), or with two
truncated forms: in N the whole N-terminal
cytoplasmic tail was truncated, whereas in
TRL the last three amino acids from the
C-terminal cytoplasmic tail were removed.
Expression was analyzed by confocal mi-
croscopy. The N mutant shows the same
apical location as the wild-type (WT) co-
transporter, whereas removal of the last three
amino acids partially disrupts apical expres-
sion. The data are adapted from reference
[14]. (B) Scheme of the PDZ-interactions be-
tween NaPi-IIa and PDZK1/NHERF1. Fig-
ure is adapted from reference [65].
that this cell line expresses an apical parathyroid hor-
mone (PTH)-responsive Na/Pi-cotransporter (NaPi-IIa)
(e.g., [12, 13]). Initial transfection experiments using
green fluorescent protein (GFP)-tagged NaPi-IIa sug-
gested that the N-terminal cytoplasmic tail is not required
for apical expression (Fig. 1A), whereas the C-terminal
cytoplasmic tail contains two determinants involved in
apical expression (sorting and/or anchoring) [14]. The
first determinant is represented by the last three amino
acids (TRL), a candidate motif for PSD95/DglA/ZO-1
(PDZ)-interactions (see below). PDZ-binding proteins
contain sequences (modules) of about 90 amino acids
involved in protein-protein interactions by binding usu-
ally to the last three residues (PDZ-binding domain) of
the corresponding partner (in this case NaPi-IIa, [15]).
Removal of the TRL sequence partially prevents apical
expression of NaPi-IIa ([14], Fig. 1A). The second deter-
minant for apical expression is located in the middle of the
C-terminal tail and involves a PR sequence [14]. By yeast
two-hybrid screening, a panel of PDZ-binding proteins
that interact specifically with the TRL motif of NaPi-
IIa was identified, among them the Na+/H+ exchange
(NHE3) regulatory factor isoforms Na/H exchanger-
regulatory factor 1 (NHERF1) and NHERF2, as well
as the (PDZ domain containing protein) PDZK1 and
PDZK2 [16] (Fig. 1B). Immunostaining of mouse prox-
imal tubules showed that, similar to NaPi-IIa, all these
interacting proteins are expressed in the apical and sub-
apical compartment of renal proximal tubules [16]; fur-
thermore, with the exception of PDZK2, which shows a
subapical expression, all of them colocalize with NaPi-
IIa within the brush border membrane (BBM) [16]. Both
NHERF isoforms contain two PDZ modules, whereas
both PDZK isoforms contain four PDZ modules (Fig. 1B;
see also Fig. 4, [16]). NHERF binds through its
C-terminal tail to members of the Merlin-Ezrin-Rodixin-
Moesin (MERM) family, which in turn mediate bind-
ing to the actin cytoskeleton [17], thus providing a
cytoskeleton/membrane anchor (Fig. 1B). Further exper-
iments in OK cells indicated that over-expression of indi-
vidual PDZ modules of NHERF1 (PDZ-1) and PDZK1
(PDZ-3) have a dominant negative effect on the apical
expression of NaPi-IIa [18]; these findings strongly sug-
gest that both interactions are involved in the apical ex-
pression of the cotransporter. This conclusion is further
supported by the phenotype of the NHERF1 knockout
mouse, which shows a reduced abundance of NaPi-IIa in
proximal BBM [19]; no such phenotype is evident in the
PDZK1 knockout model [20].
Thus, our current model predicts that NaPi-IIa is an-
chored to the BBM of proximal tubules via PDZ inter-
actions with NHERF1 and with PDZK1 (Fig. 1B). The
NHERF1/MERM interaction would link NaPi-IIa to the
actin cytoskeleton; PDZK1 could be involved in the for-
mation of a local signaling complex (regulatory scaffold,
see below). With respect to the cytoskeleton interaction,
delivery/insertion of NaPi-IIa into the BBM apparently
requires an intact microtubular network [21].
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RETRIEVAL/INTRACELLULAR TRAFFIC
Down-regulation of BBM Na/Pi-cotransport activity
is linked to endocytotic retrieval and subsequent lyso-
somal degradation of NaPi-IIa (reviewed in [1–3, 22]);
the interacting proteins NHERF1/2 and PDZK1/2 (see
above) remain at the BBM (PDZK2 subapical) (N. De-
liot et al, submitted for publication). This implies that
a dissociation of NaPi-IIa from the interacting proteins
must precede transporter internalization (N. Deliot et al,
submitted for publication). The cytoskeleton (microtubu-
lar network) seems not to be involved in the initial re-
trieval step, but is required for trafficking to the lysosomes
[21, 23].
A major component of endocytosis in the proximal
tubule is the endocytotic receptor protein megalin, which
is involved in the reabsorption of proteins in the proximal
tubule such as albumin, PTH, vitamin D3, or drugs such
aminoglycosides [24, 25]. Loss of megalin severely af-
fects the apical endocytotic machinery, as is evident from
morphologic changes such as a reduced number of dense
apical tubules (DAT) in the proximal tubule of megalin-
deficient mice [25, 26]. The fast, PTH-induced retrieval
of NaPi-IIa from the BBM is also disturbed in megalin-
deficient mice [26]. The failure to withdraw NaPi-IIa from
the BBM seems not to be due to a failure of PTH signal-
ing, but to the disturbance of an event that is common to
several distinct signaling pathways involved in NaPi-IIa
retrieval, and is downstream of activation of protein ki-
nases A, C, and G (see below; [26, 27]). Similar results
were obtained with a second mouse model with reduced
expression of megalin due to loss of receptor-associated
protein (RAP); RAP serves as a chaperone for megalin,
and prevents early degradation of megalin [27]. Taken to-
gether, these results demonstrate that intact apical endo-
cytotic machinery is a prerequisite for NaPi-IIa retrieval.
To identify the cellular traffic of NaPi-IIa to the lyso-
somes we used immunohistochemistry and antibodies
against defined markers of several intracellular compart-
ments. Kidneys from rats that had been injected with
PTH for different time periods (5, 15, 30, and 60 minutes)
before fixation have been used in these studies. The exper-
iments revealed the presence of NaPi-IIa staining in com-
partments positive for clathrin or the early endosomal
antigen (EEA1; Fig. 2). Strong NaPi-IIa staining colo-
calized together with clathrin or EEA1 only after PTH
injection, and followed a clear time course. Briefly after
PTH injection, NaPi-IIa staining (green) moved more to
a subapical compartment, and colocated less with actin
(red) staining in the BBM (Fig. 2). Simultaneously with
the disappearance of NaPi-IIa from the BBM, NaPi-IIa
staining started to colocate with staining for clathrin be-
low the BBM, indicating that the first step(s) in retrieval
may involve clathrin-coated pits (Fig. 2, after 5 and 15
minutes of PTH injection; see also [28]). NaPi-IIa and
EEA1 immunostaining appeared together only after 15
to 30 minutes after PTH injection, at a time when clathrin
and NaPi-IIa colocalization became weaker. Thus, NaPi-
IIa may travel from clathrin-coated pits to early endo-
somes (positive for EEA1), from where the protein is
then routed to lysosomes for degradation [22, 29].
In the BBM, NaPi IIa and megalin colocate, but dur-
ing the PTH-induced internalization these two proteins
do not share the same fate. Megalin is recycled back to the
membrane via DAT (reviewed in [24, 25]), and NaPi IIa is
degraded in lysosomes [28, 29] (Fig. 3). The disruption of
the endocytotic apparatus due to lack of megalin appears
to be the predominant cause for impaired endocytosis of
NaPi-IIa, even though yet unidentified interactions be-
tween the cotransporter and megalin that may play a role
cannot be excluded. After PTH injection, megalin did not
appear in clathrin or EEA1-positive compartments (D.
Bacic et al, unpublished observations), suggesting that
potential interactions between megalin and NaPi-IIa had
occurred at an earlier time point during internalization.
Proteins directly linking NaPi-IIa to the endocytotic ap-
paratus have not been identified to date.
We have documented in transfection studies using OK
cells that the third intracellular loop of NaPi-IIa con-
tains a dibasic amino acid motif (R/K-R) required for
the PTH-induced internalization ([30, 31]). This motif
was suggested to interact with peroxisomal farnesty-
lated protein (PEX) 19, and thereby, to facilitate in-
ternalization of NaPi-IIa. PEX 19 has been found in
preparations of membranes from the subapical and BBM
compartment [32]. Although in such membrane prepara-
tions cross-contaminations cannot be excluded, and lo-
cation by morphologic techniques has not been provided
[32], PEX 19 might be considered as a candidate for link-
ing NaPi-IIa to the endocytotic machinery.
EXTRA-/INTRACELLULAR
CONTROL/MECHANISMS
Novel extracellular factors in Pi homeostasis
Control of Pi homeostasis is related to a regulatory
control of renal proximal tubular Na/Pi-cotransport ac-
tivity (reviewed in [1–3, 8]). PTH, dietary Pi-intake, and
1.25 dihydroxycholecalciferol have been considered as
the major factors, and lead to a reduction of Pi reab-
sorption (PTH, high dietary intake), or to stimulation
(1.25 dihydroxycholecalciferol, low dietary intake) (re-
viewed in [1–3, 8]). An incomplete list of factors leading
to reduced Pi reabsorption includes also atrial natriuretic
peptide (ANP) [33], nitric oxide (NO) [33], and many
others (reviewed in [1–3, 8]). Alterations involving in-
volving the calcium-sensing receptor have also been de-
scribed [34]. The altered reabsorption rates have mostly
been associated with altered brush border expression of
NaPi-IIa, although at the onset of a regulatory event,
or in the recovery from a regulated state, a dissociation
between rate of proximal tubular Pi reabsorption and
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Fig. 3. Proposed intracellular traffic in NaPi-
IIa retrieval and intracellular signaling cas-
cades involved in its regulation. Parathyroid
hormone (PTH)-induced internalization of
NaPi-IIa follows clathrin-mediated endocyto-
sis. An intact endocytotic apparatus depen-
dent on the presence of megalin is crucial for
the retrieval. Finally, degradation of NaPi-IIa
in lysosomes occurs; megalin is recycled back
to the membrane. Intracellular signaling cas-
cades involved in the control of internalisation
are also schematized (see text).
BBM NaPi-IIa expression might exist (M. Levi, personal
communication).
The molecular characterization of different renal phos-
phate wasting disorders (with similar symptomatics),
such as tumor-induced osteomalacia (TIO), X-linked
hypophosphatemic rickets (XLH), and autosomal-
dominant hypophosphatemic rickets (ADHR) have led
to the identification of factors (phosphatonins: fibroblast
growth factor (FGF)-23, matrix extracellularphosphogly-
coprotein (MEPE), frizzled related protein (FRP)-4, see
below; reviewed in [7, 8, 35–37]) likely to be also involved
in the control of normal Pi homeostasis. Phosphatonins
seem to control proximal tubular Pi reabsorption. Posi-
tional cloning strategies led to the identification of genes
associated with the genetically determined Pi wasting dis-
orders XLH (phosphate regulating gene with homologies
to endopeptidases on the X-chromosome [PHEX]; [38])
and ADHR (FGF-23; [39]). Molecular characterization
of TIO led (also) to the identification of FGF-23 [40],
MEPE [41], and FRP-4 [4, 8, 42].
FGF-23 leads to a reduced BBM expression of NaPi-
IIa, and thus, to reduced Pi reabsorption [43–46]. PHEX
is suggested to be involved in the cleavage of the phospha-
turic hormone FGF-23 [35, 36, 37, 47]. This then may ex-
plain XLH with mutations in PHEX (loss of peptidase ac-
tivity) and ADHR, with mutations in FGF-23 and absent
or reduced rates of degradation induced by PHEX. In
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Fig. 2. Retrieval of NaPi-IIa from the brush border membrane. Left panel: Immunofluorescence for NaPi-IIa (green) and b-actin (red) in control
animals and rats treated with parathyroid hormone (PTH) for 5, 15, 30, or 60 minutes. In controls, distribution of NaPi-IIa in the brush border
membrane (BBM) appears homogenous (yellow appearance). After 5 minutes of PTH treatment, NaPi-IIa staining of the brush border is slightly
reduced (orange appearance), and the subapical region reveals a weak, but distinct (green) fluorescence for NaPi-IIa. With prolonged treatments (15
and 30 minutes), NaPi-IIa staining in the BBM is further reduced (orange appearance), and a large (green) fluorescent rim below the BBM appears.
At the same time, the intensity of the intracellular (green) staining below this supapical region is increased. After 60 minutes, PTH treatment leads
to a complete disappearance of NaPi-IIa from the BBM (orange/red coloring) and from the subapical region. Middle panel: Immunofluorescence
localization of NaPi-IIa (green) and clathrin (red). Right panel: NaPi-IIa (green) and early endosomal antigen 1 (EEA1) (red). After 5 and 15 minutes
of PTH treatment, NaPi-IIa colocalizes with clathrin (orange/yellow). Fifteen and 30 minutes after PTH administration, NaPi-IIa is located deeper
in the cells and overlaps with the EEA1-stained region (orange/yellow). After 60 minutes of treatment with PTH, NaPi-IIa immunoflorescence is
absent from the subapical compartment, and the NaPi-IIa has been degradated in lysosomes. Some residual NaPi-IIa staining is still visible in the
BBM. Bar = 10 lm.
the Hyp mouse model of XLH a reduced brush BBM ex-
pression of NaPi-IIa and associated transport activity was
found [48]. Similarly, in different animal systems and in
OK cells, FGF-23 was found to reduce Na/Pi-cotransport
[8, 43, 46]. FRP-4 is also over-expressed in TIO tumors
(reviewed in [8]). FRP-4 inhibits Na/Pi-cotransport in OK
cells, and infusion into mice results in phosphaturia (re-
viewed in [8], [42]). The role of MEPE in control of re-
nal Pi reabsorption is less clear. Injection of recombinant
MEPE into mice was reported to be associated with in-
creased phosphate excretion (reviewed in [8]).
Intracellular signaling
Figure 3 summarizes some of the cellular signaling
mechanisms thought to be involved in the retrieval of
NaPi-IIa from the BBM. The picture is rather incom-
plete, and describes only initial signaling events, but lacks
a description of mechanisms actually involved in the re-
trieval step (e.g., we have not been able to show a PTH-
induced alteration in phosphorylation of NaPi-IIa in OK
cells) [49]. Agonists may activate PK-A (e.g., PTH), PK-
C (e.g., PTH), and PK-G (e.g., NO, ANP). For PTH and
for ANP, signal transduction involves apical and basolat-
eral receptor interactions with (for PTH) differences in
signal transduction (for recent review see [3]). The dif-
ferent signal transduction systems may also involve the
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mitogen activated protein (MAP) kinase [extracellular
receptor kinase (ERK1/2)] [50, 51]. The participation of
the MAP kinase system is of interest with respect to the
action of the phosphatonins. For FGF-23, binding to a
membrane-associated receptor (FGFR) has been shown,
with associated MAP kinase activation, tyrosine phos-
phorylation, and subsequent inhibition of phosphate up-
take in OK cells (for review see [8], [52]). For FRP-4, an
involvement of the Wnt signaling pathway was suggested
with a possible direct link between the actions of FRP-4
and FGF-23 (reviewed in [8]).
Apical signaling complex
As indicated above, we have a lack of knowledge on
the cellular mechanisms following activation of different
signaling mechanisms and leading to the actual retrieval
of the transporter from the membrane. In Figure 1, we
have indicated that NaPi-IIa is part of an apical scaf-
fold containing NHERF1 and PDZK1. This scaffold also
contains elements that are candidates to play a role in
signal transduction leading to internalisation (e.g., to a
dissociation of NaPi-IIa from the scaffold as a first step
in internalization; see above). As illustrated in Figure 4,
NHERF1 and PDZK1 assemble protein complexes com-
prising several regulatory components that have been de-
scribed to be part of the signaling cascades activated by
different systemic factors participating in control of Pi re-
absorption and leading to an internalization of NaPi-IIa
(see above, Fig. 3). Although an interaction of NaPi-IIa
with NHERF2 was suggested from in vitro studies [16],
NHERF2 was not included in the scheme because with
a NHERF1 null mice model, evidence was obtained that
NaPi-IIa does not directly interact with NHERF2 [53].
With respect to a cAMP-dependent signaling path-
way (see above), it is of interest that both NHERF1 and
PDZK1 provide indirect anchoring sites for protein ki-
nase AI/II. In yeast, two hybrid screens, and in vitro stud-
ies PDZK1 was shown to interact with DAKAP2 [54],
which has been described to anchor PK-AI and PK-AII,
yet with different affinities [55, 56]. In vitro studies re-
vealed evidence that DAKAP2 interacts with the PDZ
domains 1, 3, and 4 of PDZK1 (unpublished results). As
DAKAP2 also contains a RGS domain [55], D-AKAP2,
in addition, may play a role in G-protein–mediated sig-
naling.
An additional anchoring site for PK-A is represented
by the MERM family member ezrin, which was shown
to interact via its N-terminal half with the C-terminal
MERM domain of NHERF1 [57]. The arrangement of
NHERF1/ezrin/PK-A has been shown to be required
for the regulation of NHE-3 [58, 59]. To date, no di-
rect functional evidences for the complexes PDZK1/D-
AKAP2/PK-A or NHERF1/ezrin/PK-A in the regulation
of NaPi-IIa are available. A somewhat more direct asso-
ciation of PK-A with NaPi-IIa was suggested to occur via
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Fig. 4. Apical regulatory scaffold. Schematic view of the interactions
of NaPi-IIa with signaling complexes scaffolded by PDZK1 () or by
NHERF1 (). Single PDZ domains are numbered starting from the N-
terminus. AKAP, PK-A anchoring protein; PL-C, phospholipase C; PK-
A, protein kinase A; PTHR1, receptor for parathyroid hormone. For
discussions, see text.
AKAP79, which has been proposed to physically interact
with NaPi-IIa in OK cells [60]. Interestingly, uncoupling
of PKA from AKAP79 by a competing peptide prevented
regulation of NaPi-IIa by PTH [60].
In contrast to PDZK1, NHERF1 also serves to position
the parathyroid hormone receptor PTHR1 and isoforms
of phospholipase Cb (Fig. 4). Originally, this interaction
pattern was described for NHERF2 [61, 62]. Recent stud-
ies performed with the OK cell strain OKH demonstrated
that the complex NHERF1/PTHR1/PL-Cb is directly in-
volved in the regulation of NaPi-IIa and, in addition,
in PTH-mediated increase of intracellular calcium [63],
which may be mediated by a NHERF1-associated cal-
cium channel, such as TRP4 [64].
As we have previously shown [54, 65], a number of pro-
teins can interact with the same PDZ domain (PDZ1) of
NHERF1. Because NHERF1 was shown to form dimers
due to PDZ-PDZ interactions [66, 67], it appears likely
that self-association of NHERF1 provides a mechanism
that links all factors into one complex. Such complexes
are linked via ezrin and via b-actin to the microvillar cy-
toskeleton. The importance of this stabilization of the
NHERF1 regulatory complex to b-actin has recently
been demonstrated by the disruption of F-actin with cy-
tochalasin D [62].
CONCLUSION AND OUTLOOK
Initiated by the cloning of the renal Na/Pi-
cotransporter (NaPi-IIa), and also based on the subse-
quent documentation of its important role in proximal
tubular Pi reabsorption, an advanced knowledge on
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cellular mechanisms in proximal tubular Pi handling
has been developed in the past decade. Surprisingly,
it was found that regulation is mostly altered via ex-
pression of NaPi-IIa, and that membrane retrieval is
followed by lysosomal degradation. Also, pathophysi-
ologic changes in renal Pi handling are linked to al-
tered expression of NaPi-IIa. The molecular character-
ization of pathophysiologic situations led to the iden-
tification of a variety of novel factors (phosphatonins),
which may also play important roles in the normal
control of Pi reabsorption. However, we have a lim-
ited understanding of the cellular processes leading to
membrane retrieval/internalization of NaPi-IIa—initial
signal transduction events are multiple, and may con-
verge and/or are interdependent. The type IIa transporter
is likely part of a large protein complex important for api-
cal positioning, as well as for regulation/retrieval.
Future experiments should concentrate on several as-
pects. We need a more complete understanding of the
role of cellular mechanisms involved in the regulation of
the membrane retrieval of NaPi-IIa, in particular, also
of the role of the different partners and of the dynamics
of interactions/dissociations within the apical/regulatory
scaffolds. In part, these studies are made difficult by
the lack of an appropriate in vitro model. OK cells cer-
tainly offer some possibilities, but they have the ma-
jor problem of being very slow in terms of regulatory
responses (e.g., for PTH, hours in OK cells compared
to minutes in mice and rats), and appear to lack some
proteins found in the native proximal tubules. Thus, it
seems to be important to work also on rat and mice
tubular preparations in establishing schemes on regu-
latory cascades that are representative for the physi-
ologic situation. Although we assume that NaPi-IIa is
the key player (in part supported by NaPi-IIc), there
is the possibility of an additional Na/Pi-cotransporter,
which may explain some apparent discrepancies between
NaPi-IIa/c expression, Na/Pi-cotransport activity (?), and
renal Pi reabsorption. Future work will also concen-
trate on structural and functional aspects of the trans-
porter molecule itself. To understand NaPi-IIa–mediated
Na/Pi-cotransport and its regulation we need to com-
plement studies on structure/function relationships (re-
viewed in [68]) also by two- and three-dimensional struc-
tural analysis, which is obviously rather difficult. Finally,
we have to indicate that the basolateral exit step for Pi is
unidentified (reviewed in [1–3]).
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